Skip to main content
STRATEC SE logo

STRATEC SE — Investor Relations & Filings

Ticker · SBS ISIN · DE000STRA555 LEI · 529900ZZJWANAFSPGV30 F Manufacturing
Open in API
Filings indexed 828 across all filing types
Latest filing 2002-04-18 M&A Activity
Country DE Germany
Listing F SBS

About STRATEC SE

https://www.stratec.com/home

STRATEC SE is a global partner specializing in the design and manufacturing of fully automated solutions for OEM partners in the clinical diagnostics and life sciences industries. The company provides a comprehensive, integrated portfolio covering the entire value chain, from development and design to production and quality assurance. Its core offerings include fully automated analyzer systems (instrumentation), custom software and digital IoT solutions, and smart polymer-based consumables. Leveraging decades of experience and a broad technology base, STRATEC delivers tailored, high-quality systems that meet stringent regulatory standards, enabling its partners to bring advanced diagnostic and life science products to market.

Recent filings

Filing Released Lang Actions
Stratec Biomedical Sys. english
M&A Activity Classification · 1% confidence The document is an 'Ad-hoc' announcement dated April 18, 2002, transmitted via DGAP, which is a common channel for regulatory news in Germany. It announces the successful conclusion of a long-term contract between Stratec and Bayer Diagnostics regarding the development and supply of an analyzer system. This type of material, which reports on a significant business event (a major contract) outside of standard periodic financial reporting (like 10-K or IR), typically falls under general regulatory announcements or news disclosures. Since it is not a specific filing like a Director's Dealing (DIRS), Earnings Release (ER), or Capital Change (CAP), and it is a formal, time-sensitive disclosure, it best fits the 'Regulatory Filings' category as a miscellaneous, mandatory disclosure, or the 'Report Publication Announcement' (RPA) if it were announcing the release of a different report. Given the content is the news itself (a contract announcement) and not an announcement *about* a report, 'RNS' (Regulatory Filings - general regulatory announcements and fallback) is the most appropriate classification.
2002-04-18 English
Stratec Biomedical Sys. deutsch
Regulatory Filings Classification · 1% confidence The document is an 'Ad-hoc' announcement dated April 18, 2002, reporting the successful conclusion of a long-term contract between Stratec and Bayer Diagnostics for the development and supply of an analysis system. This type of announcement, detailing a significant business agreement or contract signing, does not fit the specific definitions for financial reports (10-K, IR, ER, MRQ), shareholder actions (AGM-R, DVA, DIV), or management changes (MANG). It is a general, material corporate disclosure required under German securities law (§ 15 WpHG). Since it is a specific, material business event announcement that isn't covered by other specific codes (like M&A (TAR) or Financing (CAP)), the most appropriate general category for significant, non-standard regulatory disclosures is 'Regulatory Filings' (RNS). The document length is short (3382 chars), but it is the primary disclosure itself, not an announcement *about* another report, so the RPA rule does not strictly apply here.
2002-04-18 German
Stratec Biomedical Sys.
Capital/Financing Update Classification · 1% confidence The document text explicitly announces the successful completion of a capital increase ('erfolgreiche Kapitalerhöhung') through the issuance of new shares, which strengthened the equity base. This directly relates to fundraising, financing activities, and capital structure changes. Based on the definitions, this aligns perfectly with the 'Capital/Financing Update' category (Code: CAP). The document is a news release detailing the transaction, not just an announcement of a report.
2002-03-27 German
Stratec Biomedical Sys. english
Earnings Release Classification · 1% confidence The document is an 'Ad-hoc-announcement' dated February 27, 2002, presenting preliminary financial figures for the fiscal year 2001, including EPS, Net Profit, EBT, EBIT, EBITDA, Turnover, and Cash Flow. This content strongly indicates an initial release of periodic financial results, which aligns with the definition of an Earnings Release (ER). Crucially, the text explicitly states: 'The annual report for the fiscal year 2001, which includes the figures in accordance with the International Accounting Standards (IAS) in addition to the figures in accordance with German Commercial Law, is expected to be dispatched via direct mail on April 15, 2002.' This confirms that the current document is NOT the full Annual Report (10-K) but rather the preliminary results announcement. Given the focus on key financial metrics released prior to the full audit and the official annual report release, the classification is Earnings Release (ER). FY 2001
2002-02-27 English
Stratec Biomedical Sys. english
Earnings Release Classification · 1% confidence The document is an 'Ad-hoc-announcement' dated November 14, 2001, reporting that the estimated turnover for the entire fiscal year 2001 has already been surpassed after only nine months (ending Sept 30, 2001). It provides key financial highlights (turnover, EPS) and mentions that the full '3rd quarter 2001 report will be available for download' later that day. This structure—a brief announcement summarizing key results and pointing to a more detailed report—is characteristic of an Earnings Release (ER). It is not the comprehensive report itself (like 10-K or IR), nor is it a general regulatory filing (RNS) given the specific financial nature. 9M 2001
2001-11-14 English
Stratec Biomedical Sys.
Earnings Release Classification · 1% confidence The document is an 'Ad-hoc-Mitteilung' (Ad-hoc announcement) dated July 5, 2001, reporting preliminary figures for the first half of 2001 ('1. Halbjahr 2001'). It details key financial highlights such as revenue increase (Umsatzsteigerung) and EBIT growth. This format, focusing on preliminary key results for a specific reporting period (half-year) before the full report is released, aligns perfectly with the definition of an Earnings Release (ER). Furthermore, the text explicitly states that the final 'Halbjahresbericht' (Half-year report) will be available later (August 10, 2001), confirming this document is the initial announcement of results, not the comprehensive report itself (which would be classified as IR). H1 2001
2001-07-05 German

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.